Samuel Murray
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 17
- Renal cell carcinoma treatment 7
- Oncology 19
- Cancer Immunotherapy and Biomarkers 5
- HER2/EGFR in Cancer Research 5
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Issa J Dahabreh (10 shared papers)Helena Linardou (16 shared papers)P. Kosmidis (9 shared papers)Dimitrios Bafaloukos (7 shared papers)Fotios Siannis (3 shared papers)Christos Papadimitriou (3 shared papers)D. Kanaloupiti (1 shared paper)George Fountzilas (8 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Expert Opinion on Therapeutic Patents (2 papers)Annals of Oncology (2 papers)Journal of Clinical Pathology (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Samuel Murray
48 papers receiving 2.4k citations
Samuel Murray's Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 986
- Cancer Research 498
- Pulmonary and Respiratory Medicine 978
- Infectious Diseases 240
- Pathology and Forensic Medicine 194
Countries citing papers authored by Samuel Murray
This map shows the geographic impact of Samuel Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Murray more than expected).
Fields of papers citing papers by Samuel Murray
This network shows the impact of papers produced by Samuel Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Murray. The network helps show where Samuel Murray may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer Hit paper breakdown → | 2008 | 599 |
| 2 | 2011 | 246 | |
| 3 | 2009 | 194 | |
| 4 | 2008 | 168 | |
| 5 | 2014 | 155 | |
| 6 | 2009 | 116 | |
| 7 | 2008 | 116 | |
| 8 | 2017 | 101 | |
| 9 | 2007 | 76 | |
| 10 | 2010 | 56 | |
| 11 | 2008 | 54 | |
| 12 | 2008 | 47 | |
| 13 | 2021 | 47 | |
| 14 | 2007 | 46 | |
| 15 | 2010 | 42 | |
| 16 | 2013 | 41 | |
| 17 | 2010 | 39 | |
| 18 | 2022 | 39 | |
| 19 | 2014 | 33 | |
| 20 | 2006 | 28 |
About Samuel Murray
Samuel Murray is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Cancer Genomics and Diagnostics (10 papers), Renal cell carcinoma treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), HER2/EGFR in Cancer Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (986 citations), Cancer Research (498 citations), Pulmonary and Respiratory Medicine (978 citations), Infectious Diseases (240 citations) and Pathology and Forensic Medicine (194 citations). Samuel Murray has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Issa J Dahabreh, Helena Linardou, P. Kosmidis, Dimitrios Bafaloukos, Fotios Siannis, Christos Papadimitriou, D. Kanaloupiti, George Fountzilas, Evangelos Briasoulis and Menelaos Manoloukos. Their work appears in journals such as Journal of Clinical Oncology, Expert Opinion on Therapeutic Patents, Annals of Oncology, Journal of Clinical Pathology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.